Tag: immune-related adverse events

A network meta-analysis of 58 phase III trials covering 36,664 patients ranks the safety of 20 immune checkpoint inhibitors combined ...

A new transcriptomic study reveals that biological sex shapes how regulatory T cells reprogram during checkpoint inhibitor toxicities and autoimmune ...

A systematic review of 116 case reports reveals that immune checkpoint inhibitors can trigger rare but often fatal heart complications, ...

A Japanese study found that immune-related adverse events during checkpoint inhibitor therapy for advanced gastric cancer were independently linked to ...

In a groundbreaking study published recently in Nature Communications, researchers have delved into the intricate immune mechanisms responsible for the ...

In recent years, immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, offering new hope to patients with various malignancies. These ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, opening new horizons in the fight against malignancies by unleashing the immune ...

Immune checkpoint inhibitors (ICIs) have revolutionized oncology, marking a profound leap forward in cancer immunotherapy. By targeting and blocking inhibitory ...

A groundbreaking multinational study has shed new light on immune-mediated adverse events (irAEs) associated with the combination therapy of atezolizumab ...

A groundbreaking editorial recently published in the latest volume of Oncoscience sheds new light on the complex relationship between immune ...